炎性乳腺癌、三联治疗与死亡率:居住地是否重要
本研究基于监测、流行病学和最终结果(SEER)项目2010至2016年诊断的炎性乳腺癌(T4d)患者,按社区社会经济地位分层,评估三联治疗与疾病特异性死亡的关系。共纳入4374例,社区社会经济地位组间接受三联治疗无差异(P=0.19);低、中社区社会经济地位与疾病特异性死亡无关联,三阴性亚型和黑人种族与更高的疾病特异性死亡相关。
要点
- 社区社会经济地位低、中组与高组间接受三联治疗无差异(P=0.19)。
- 低社区社会经济地位(HR 1.13,95%CI 0.98-1.30)与疾病特异性死亡无关联。
- 三阴性亚型(HR 2.66,95%CI 2.21-3.20)和黑人种族(HR 1.41,95%CI 1.16-1.72)与更高疾病特异性死亡相关。
核心结论
- 在SEER项目的炎性乳腺癌患者中,疾病特异性死亡似乎由肿瘤生物学和患者特征驱动,而非治疗差异或社区社会经济地位。
研究设计与样本
- 基于监测、流行病学和最终结果(SEER)项目的队列研究,纳入2010至2016年诊断的炎性乳腺癌(T4d)患者共4374例。
- 按美国国家癌症研究所普查区水平指数将队列分为低、中、高社区社会经济地位组。
- 三联治疗定义为接受改良根治性乳房切除术、化疗和放射治疗。
- 采用双变量分析、对数秩检验和Cox比例风险模型(风险比,95%置信区间)评估社区社会经济地位、三联治疗与疾病特异性死亡的关系。
主要发现
- 社区社会经济地位组间接受三联治疗无差异(P=0.19)。
- 多变量分析中,低社区社会经济地位(HR 1.13,95%CI 0.98-1.30;参照高社区社会经济地位)与疾病特异性死亡无关联。
- 中社区社会经济地位(HR 1.01,95%CI 0.88-1.64;参照高社区社会经济地位)与疾病特异性死亡无关联。
- 三阴性亚型(HR 2.66,95%CI 2.21-3.20;参照Luminal A型)与更高的疾病特异性死亡相关。
- 黑人种族(HR 1.41,95%CI 1.16-1.72;参照白人)与更高的疾病特异性死亡相关。
关键数值与推荐
- 三联治疗定义为接受改良根治性乳房切除术、化疗和放射治疗。
- 社区社会经济地位分组依据美国国家癌症研究所普查区水平指数分为低、中、高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The objective of this study is to examine the associations among neighborhood socioeconomic status, trimodal treatment, and disease-specific mortality among inflammatory breast cancer patients using data from the Surveillance, Epidemiology, and End Results program. METHODS: Patients diagnosed with inflammatory breast cancer (T4d) from 2010 to 2016 were identified in the Surveillance, Epidemiology, and End Results program. The cohort was stratified into neighborhood socioeconomic status groups (low, middle, high) based on National Cancer Institute census tract-level index. Trimodal treatment was defined as receipt of modified radical mastectomy, chemotherapy, and radiation therapy. Bivariable analysis, log-rank test, and a Cox proportional hazards model (hazard ratio, 95% confidence interval) were conducted to evaluate the relationship between neighborhood socioeconomic status, trimodal treatment, and disease-specific mortality. RESULTS: In total, 4,374 patients met study criteria. There was no difference between the neighborhood socioeconomic status groups in receipt of trimodal treatment (P = .19). On multivariable analysis, there was no association between low neighborhood socioeconomic status (hazard ratio 1.13, 0.98-1.30; ref high neighborhood socioeconomic status) or middle neighborhood socioeconomic status (hazard ratio 1.01, 0.88-1.64; ref high neighborhood socioeconomic status) and disease-specific mortality. Notably, triple negative subtype (hazard ratio 2.66, 2.21-3.20; ref luminal A) and Black race (hazard ratio 1.41, 1.16-1.72; ref White) were associated with a higher disease-specific mortality. CONCLUSION: For inflammatory breast cancer patients in the Surveillance, Epidemiology, and End Results program, disease-specific mortality appears to be driven by tumor biology and patient characteristics instead of treatment disparities or neighborhood socioeconomic status.
引用
- Relation T, Li Y, Fisher JL, et al. Inflammatory breast cancer, trimodal treatment, and mortality: Does where you live matter? Surgery. 2021. PMID: 34857388. doi:10.1016/j.surg.2021.08.061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。